Stratification of Risk of Progression to Colectomy in Ulcerative Colitis using Measured and Predicted Gene Expression
Angela Mo, Sini NagpaliD, Kyle GettleriD, Talin HarituniansiD, Mamta GiriiD, Yael HabermaniD, Rebekah A. KarnsiD, Jarod Prince, Dalia ArafatiD, Nai-Yun HsuiD, Ling-shiang F. ChuangiD, Carmen ArgmanniD, Andrew KasarskisiD, Mayte Suárez‐FariñasiD, Nathan Gotman, Emebet MengeshaiD, Suresh VenkateswaraniD, Paul A. RufoiD, Susan S. BakeriD, Cary G. Sauer, James F. MarkowitziD, Marian D. Pfefferkorn, Joel R. RoshiD, Brendan M. Boyle, David R. MackiD, , Greg C. GibsoniD
Abstract
An important goal of clinical genomics is to be able to estimate the risk of adverse disease outcomes. Between 5% and 10% of ulcerative colitis (UC) patients require colectomy within five years of diagnosis, but polygenic risk scores (PRS) utilizing findings from GWAS are unable to provide meaningful prediction of this adverse status. By contrast, in Crohns disease, gene expression profiling of GWAS-significant genes does provide some stratification of risk of progression to complicated disease in the form of a Transcriptional Risk Score (TRS). Here we demonstrate that both measured (TRS) and polygenic predicted gene expression (PPTRS) identify UC patients at 5-fold elevated risk of colectomy with data from the PROTECT clinical trial and UK Biobank population cohort studies, independently replicated in an NIDDK-IBDGC dataset. Prediction of gene expression from relatively small transcriptome datasets can thus be used in conjunction with transcriptome-wide association studies to stratify risk of disease complications.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Improving Consistency in Colorectal Cancer Genetic Risk Assessment and Return of Results Through an Integrated Polygenic Risk Score
Huy Tran, Ashley J Mulford, … Jianfeng Xu·medRxiv·Nov 9, 2026
- An extremes of phenotype approach confirms significant genetic heterogeneity in patients with ulcerative colitis.
Sally Mortlock, Anton Lord, … Graham L Radford‐Smith·Journal of Crohn s and ColitisPeer-reviewed·Sep 14, 2022
- Precision Colorectal Cancer Screening with Polygenic Risk Score
Tõnis Tasa, Mikk Puustusmaa, … Peeter Padrik·medRxiv·Aug 19, 2020
- Conserved transcriptomic profile between mouse and human colitis allows temporal dynamic visualization of IBD-risk genes and unsupervised patient stratification
P. Czarnewski, S. M. Parigi, … E. J. Villablanca·bioRxiv·Jan 16, 2019
- Colorectal cancer risk stratification using a polygenic risk score in symptomatic patients presenting to primary care -- a UK Biobank retrospective cohort study
Bethan Mallabar-Rimmer, Samuel WD Merriel, … Harry Green·European Journal of Human GeneticsPeer-reviewed·Aug 1, 2024
- Linking Gene Expression to Clinical Outcomes in Pediatric Crohn's Disease Using Machine Learning
Kevin A. Chen, Nina C. Nishiyama, … Shehzad Z. Sheikh·Scientific ReportsPeer-reviewed·Feb 1, 2024